DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES
To provide a method for the treatment of subjects having CD20-positive cell proliferative disorders (e.g., B cell proliferative disorders, such as non-Hodgkin's lymphomas).SOLUTION: The invention pertains to the treatment of subjects having a B cell proliferative disorder by intravenous adminis...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LI CHIUNG CAROL ELAINE O'HEAR BRENDAN CHRISTIAN BENDER |
| description | To provide a method for the treatment of subjects having CD20-positive cell proliferative disorders (e.g., B cell proliferative disorders, such as non-Hodgkin's lymphomas).SOLUTION: The invention pertains to the treatment of subjects having a B cell proliferative disorder by intravenous administration of an anti-CD20/anti-CD3 bispecific antibody (e.g., mosunetuzumab).SELECTED DRAWING: None
【課題】ＣＤ２０陽性細胞増殖性障害（例えば、非ホジキンリンパ腫等のＢ細胞増殖性障害）を有する対象を処置する方法を提供する。【解決手段】抗ＣＤ２０／抗ＣＤ３二重特異性抗体（例えば、モスネツズマブ）の静脈内投与により、Ｂ細胞増殖性障害を有する対象を処置する。【選択図】なし |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2023153118A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2023153118A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2023153118A3</originalsourceid><addsrcrecordid>eNrjZHBy8Q_29HNXcPMPUggJcnUM8XX1C1EI9wzxUHD0C_HUdXYxMtCHsowVnDyDA1ydPd08ncGyTv4unq7BPAysaYk5xam8UJqbQcnNNcTZQze1ID8-tbggMTk1L7Uk3ivAyMDI2NDU2NDQwtGYKEUAHnUrIw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES</title><source>esp@cenet</source><creator>LI CHIUNG ; CAROL ELAINE O'HEAR ; BRENDAN CHRISTIAN BENDER</creator><creatorcontrib>LI CHIUNG ; CAROL ELAINE O'HEAR ; BRENDAN CHRISTIAN BENDER</creatorcontrib><description>To provide a method for the treatment of subjects having CD20-positive cell proliferative disorders (e.g., B cell proliferative disorders, such as non-Hodgkin's lymphomas).SOLUTION: The invention pertains to the treatment of subjects having a B cell proliferative disorder by intravenous administration of an anti-CD20/anti-CD3 bispecific antibody (e.g., mosunetuzumab).SELECTED DRAWING: None
【課題】ＣＤ２０陽性細胞増殖性障害（例えば、非ホジキンリンパ腫等のＢ細胞増殖性障害）を有する対象を処置する方法を提供する。【解決手段】抗ＣＤ２０／抗ＣＤ３二重特異性抗体（例えば、モスネツズマブ）の静脈内投与により、Ｂ細胞増殖性障害を有する対象を処置する。【選択図】なし</description><language>eng ; jpn</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231017&DB=EPODOC&CC=JP&NR=2023153118A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231017&DB=EPODOC&CC=JP&NR=2023153118A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LI CHIUNG</creatorcontrib><creatorcontrib>CAROL ELAINE O'HEAR</creatorcontrib><creatorcontrib>BRENDAN CHRISTIAN BENDER</creatorcontrib><title>DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES</title><description>To provide a method for the treatment of subjects having CD20-positive cell proliferative disorders (e.g., B cell proliferative disorders, such as non-Hodgkin's lymphomas).SOLUTION: The invention pertains to the treatment of subjects having a B cell proliferative disorder by intravenous administration of an anti-CD20/anti-CD3 bispecific antibody (e.g., mosunetuzumab).SELECTED DRAWING: None
【課題】ＣＤ２０陽性細胞増殖性障害（例えば、非ホジキンリンパ腫等のＢ細胞増殖性障害）を有する対象を処置する方法を提供する。【解決手段】抗ＣＤ２０／抗ＣＤ３二重特異性抗体（例えば、モスネツズマブ）の静脈内投与により、Ｂ細胞増殖性障害を有する対象を処置する。【選択図】なし</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHBy8Q_29HNXcPMPUggJcnUM8XX1C1EI9wzxUHD0C_HUdXYxMtCHsowVnDyDA1ydPd08ncGyTv4unq7BPAysaYk5xam8UJqbQcnNNcTZQze1ID8-tbggMTk1L7Uk3ivAyMDI2NDU2NDQwtGYKEUAHnUrIw</recordid><startdate>20231017</startdate><enddate>20231017</enddate><creator>LI CHIUNG</creator><creator>CAROL ELAINE O'HEAR</creator><creator>BRENDAN CHRISTIAN BENDER</creator><scope>EVB</scope></search><sort><creationdate>20231017</creationdate><title>DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES</title><author>LI CHIUNG ; CAROL ELAINE O'HEAR ; BRENDAN CHRISTIAN BENDER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2023153118A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LI CHIUNG</creatorcontrib><creatorcontrib>CAROL ELAINE O'HEAR</creatorcontrib><creatorcontrib>BRENDAN CHRISTIAN BENDER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LI CHIUNG</au><au>CAROL ELAINE O'HEAR</au><au>BRENDAN CHRISTIAN BENDER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES</title><date>2023-10-17</date><risdate>2023</risdate><abstract>To provide a method for the treatment of subjects having CD20-positive cell proliferative disorders (e.g., B cell proliferative disorders, such as non-Hodgkin's lymphomas).SOLUTION: The invention pertains to the treatment of subjects having a B cell proliferative disorder by intravenous administration of an anti-CD20/anti-CD3 bispecific antibody (e.g., mosunetuzumab).SELECTED DRAWING: None
【課題】ＣＤ２０陽性細胞増殖性障害（例えば、非ホジキンリンパ腫等のＢ細胞増殖性障害）を有する対象を処置する方法を提供する。【解決手段】抗ＣＤ２０／抗ＣＤ３二重特異性抗体（例えば、モスネツズマブ）の静脈内投与により、Ｂ細胞増殖性障害を有する対象を処置する。【選択図】なし</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; jpn |
| recordid | cdi_epo_espacenet_JP2023153118A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T08%3A51%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LI%20CHIUNG&rft.date=2023-10-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2023153118A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |